{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:21:46Z","timestamp":1778998906673,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejpb.2020.02.014","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T21:37:03Z","timestamp":1582839423000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects"],"prefix":"10.1016","volume":"150","author":[{"given":"Bart","family":"Hens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imke","family":"Masuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"Deloose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raf","family":"Mols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.02.014_b0005","first-page":"79","article-title":"Exploring gastrointestinal variables affecting drug and formulation behavior: methodologies, challenges and opportunities","volume":"59","author":"Hens","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0010","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0016-5085(90)91150-5","article-title":"The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids","volume":"99","author":"Oberle","year":"1990","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ejpb.2020.02.014_b0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01061761","article-title":"The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon","volume":"15","author":"Oberle","year":"1987","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1211\/0022357022511","article-title":"Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine","volume":"56","author":"Kostewicz","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.02.014_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1208\/s12248-018-0217-6","article-title":"Measuring the impact of gastrointestinal variables on the systemic outcome of two suspensions of posaconazole by a PBPK Model","volume":"20","author":"Hens","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.02.014_b0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2014.07.008","article-title":"Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools","volume":"63","author":"Hens","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2019.04.003","article-title":"The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group","volume":"134","author":"Koziolek","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0040","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1021\/acs.molpharmaceut.8b00736","article-title":"Linking the gastrointestinal behavior of ibuprofen with the systemic exposure between and within humans-part 2: fed state","volume":"15","author":"Paix\u00e3o","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","article-title":"The migrating motor complex: control mechanisms and its role in health and disease","volume":"9","author":"Deloose","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejpb.2020.02.014_b0050","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI108740","article-title":"The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine","volume":"59","author":"Vantrappen","year":"1977","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2020.02.014_b0055","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/acs.molpharmaceut.7b00426","article-title":"Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs","volume":"14","author":"Hens","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0060","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1021\/acs.molpharmaceut.8b00515","article-title":"Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions","volume":"15","author":"Bermejo","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0065","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/AAC.39.8.1671","article-title":"Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole","volume":"39","author":"Chin","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2020.02.014_b0070","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/11592630-000000000-00000","article-title":"Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations","volume":"50","author":"Walravens","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2020.02.014_b0075","unstructured":"Food & Drug Administration, Referencing Approved Drug Products in ANDA Submissions: Guidance for Industry, (2017). https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM536962.pdf (accessed April 18, 2017)."},{"key":"10.1016\/j.ejpb.2020.02.014_b0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jcpt.12535","article-title":"Evaluation of real-life dosing of oral medicines with respect to fluid and food intake in a Dutch-speaking population","volume":"42","author":"Hens","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejpb.2020.02.014_b0085","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/jps.24690","article-title":"Supersaturation and precipitation of posaconazole upon entry in the upper small intestine in humans","volume":"105","author":"Hens","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105117","article-title":"The influence of gastric motility on the intraluminal behavior of fosamprenavir","volume":"142","author":"Braeckmans","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2014.01.009","article-title":"The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC","volume":"57","author":"Tsume","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpb.2016.09.014","article-title":"Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers","volume":"109","author":"Rubbens","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0105","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3748\/wjg.15.990","article-title":"Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis","volume":"15","author":"Zheng","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2020.02.014_b0110","unstructured":"Food & Drug Administration, Guidance for Industry: Bioanalytical Method Validation, (2001). https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM070107.pdf (accessed April 18, 2017)."},{"key":"10.1016\/j.ejpb.2020.02.014_b0115","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.02.014_b0120","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1021\/acs.molpharmaceut.7b00396","article-title":"In silico modeling approach for the evaluation of gastrointestinal dissolution, supersaturation, and precipitation of posaconazole","volume":"14","author":"Hens","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2982.2000.00204.x","article-title":"Twenty-four hour ambulatory antroduodenal manometry in normal subjects (co-operative study)","volume":"12","author":"Bortolotti","year":"2000","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejpb.2020.02.014_b0130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF01296429","article-title":"Variability of migrating motor complex in humans","volume":"37","author":"Dooley","year":"1992","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF01489315","article-title":"Motilin and the interdigestive migrating motor complex in man","volume":"24","author":"Vantrappen","year":"1979","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejps.2016.08.060","article-title":"The dynamic gastric environment and its impact on drug and formulation behaviour","volume":"96","author":"Van Den Abeele","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13540","article-title":"Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participants","volume":"31","author":"Masuy","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejpb.2020.02.014_b0150","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3945\/ajcn.115.113456","article-title":"The motilin receptor agonist erythromycin stimulates hunger and food intake through a cholinergic pathway","volume":"103","author":"Deloose","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejpb.2020.02.014_b0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejps.2017.06.037","article-title":"In vitro simulation of realistic gastric pressure profiles","volume":"107","author":"Schneider","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0160","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1208\/s12249-018-1022-3","article-title":"Influence of postprandial intragastric pressures on drug release from gastroretentive dosage forms","volume":"19","author":"Schneider","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2020.02.014_b0165","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.xphs.2017.03.039","article-title":"The effect of sparkling water on intraluminal formulation behavior and systemic drug performance","volume":"106","author":"Van Den Abeele","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.1973.tb08339.x","article-title":"The dependence of paracetamol absorption on the rate of gastric emptying","volume":"47","author":"Heading","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.02.014_b0175","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2018.07.017","article-title":"Exploring gastric drug absorption in fasted and fed state rats","volume":"548","author":"Rubbens","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ajcn\/nqy004","article-title":"Effects of caloric and noncaloric sweeteners on antroduodenal motility, gastrointestinal hormone secretion and appetite-related sensations in healthy subjects","volume":"107","author":"Meyer-Gerspach","year":"2018","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejpb.2020.02.014_b0185","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/0016-5085(92)91431-3","article-title":"Adaptive changes in the pyloric motor response to intraduodenal dextrose in normal subjects","volume":"103","author":"Edelbroek","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2020.02.014_b0190","doi-asserted-by":"crossref","first-page":"E743","DOI":"10.1152\/ajpendo.00159.2007","article-title":"Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men","volume":"293","author":"Pilichiewicz","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2020.02.014_b0195","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/gut.29.10.1349","article-title":"Stimulation of pyloric motility by intraduodenal dextrose in normal subjects","volume":"29","author":"Heddle","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2020.02.014_b0200","doi-asserted-by":"crossref","first-page":"R360","DOI":"10.1152\/ajpregu.2000.278.2.R360","article-title":"Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans","volume":"278","author":"Rayner","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejpb.2020.02.014_b0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2016.10.027","article-title":"Exploring the link between gastric motility and intragastric drug distribution in man","volume":"112","author":"Van Den Abeele","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpb.2018.05.033","article-title":"Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach","volume":"129","author":"Paix\u00e3o","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jps.22750","article-title":"Supersaturating drug delivery systems: fast is not necessarily good enough","volume":"101","author":"Augustijns","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.02.014_b0220","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/mp100377m","article-title":"Excipient-mediated supersaturation stabilization in human intestinal fluids","volume":"8","author":"Bevernage","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.02.014_b0225","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s11095-017-2144-0","article-title":"Impact of micellar surfactant on supersaturation and insight into solubilization mechanisms in supersaturated solutions of atazanavir","volume":"34","author":"Indulkar","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.02.014_b0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11095-018-2441-2","article-title":"Crystallization from supersaturated solutions: role of lecithin and composite simulated intestinal fluid","volume":"35","author":"Indulkar","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.02.014_b0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2018.01.039","article-title":"Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach","volume":"115","author":"Hens","year":"2018","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:36:17Z","timestamp":1760546177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120300552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":47,"alternative-id":["S0939641120300552"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.02.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}